Metropolitan Life Insurance Company (MetLife)’s Savara SVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,602
Closed -$17.9K 1867
2024
Q1
$17.9K Sell
3,602
-1,739
-33% -$8.4K ﹤0.01% 1915
2023
Q4
$25.1K Hold
5,341
﹤0.01% 1815
2023
Q3
$20.2K Buy
5,341
+1,140
+27% +$4.06K ﹤0.01% 1897
2023
Q2
$13.4K Buy
+4,201
New +$9.87K ﹤0.01% 2138
2019
Q3
Sell
-11,354
Closed -$26.9K 2622
2019
Q2
$26.9K Hold
11,354
﹤0.01% 2570
2019
Q1
$83.7K Buy
+11,354
New +$85.5K ﹤0.01% 2414
2018
Q4
Sell
-9,214
Closed -$103K 2569
2018
Q3
$103K Hold
9,214
﹤0.01% 2440
2018
Q2
$104K Buy
+9,214
New +$92.4K ﹤0.01% 2299

Other funds holding SVRA

Metropolitan Life Insurance Company (MetLife)'s SVRA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Savara (SVRA) in Q2 2024, closing a stake of 3,602 shares — an estimated $17.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in SVRA in Q2 2018 and held it in 8 quarters. The position peaked at $104K in Q2 2018. 132 funds tracked by Wall St. Rank hold SVRA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Savara position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 3,602 Savara shares in Q2 2024, an estimated $17.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Savara in Q2 2018 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Savara position peaked at $104K in Q2 2018.
  • 132 funds tracked by Wall St. Rank held Savara as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.